FDA approves pancreatic cancer drug that extends patients' lives The Washington PostF.D.A. Approves the Drug Daraxonrasib That's Poised to Transform Pancreatic Cancer The New York TimesFDA approves once-daily pill for deadly cancer after patients' survival rates nearly double Fox NewsU.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable dis
